Quarterly report pursuant to Section 13 or 15(d)

STOCKBASED COMPENSATION

v3.21.2
STOCKBASED COMPENSATION
6 Months Ended
Sep. 30, 2021
STOCKBASED COMPENSATION  
NOTE 18 - STOCK-BASED COMPENSATION

NOTE 18 – STOCK BASED COMPENSATION

 

During the six months ended September 30, 2021, a total of 1,031,500 restricted shares were awarded to key employees. The compensation expense related to restricted stock grants was $4,561 during the three months ended September 30, 2021, and $476 during three months ended September 30, 2020. The compensation expense related to restricted stock grants was $6,722 during the six months ended September 30, 2021, and $947 during six months ended September 30, 2020. As of September 30, 2021, there was $33,459 of total unrecognized compensation cost related to non-vested shares of common stock granted. The cost is expected to be recognized over a weighted average period of 4.62 years.

 

The Company has determined the fair value of restricted shares awarded during the six months ended September 30, 2021 using the Monte Carlo valuation model based on the following key assumptions:

 

Term (years)

 

 

5

 

Volatility

 

 

41.5 %

Risk-free rate

 

 

0.06 %

The table below summarizes the activity for the Company’s restricted stock outstanding during the six months ended September 30, 2021:

 

 

 

Shares

 

 

Weighted

Average

Fair Value

 

Outstanding, at March 31, 2021

 

 

15,000

 

 

$ 775

 

Granted

 

 

1,031,500

 

 

 

39,465

 

Vested

 

 

-

 

 

 

-

 

Forfeited/cancelled/expired

 

 

-

 

 

 

-

 

Outstanding, at September 30, 2021

 

 

1,046,500

 

 

$ 40,240

 

 

During the six months ended September 30, 2021 and 2020, no stock options were awarded. Total compensation expense related to outstanding options was $0 for the three months ended September 30, 2021, and $54 for the three months ended September 30, 2020. During the six months ended September 30, 2021, options to purchase a total of 60,000 shares were exercised.

 

The Company has determined the fair value of such stock options using the Black Scholes option valuation model based on the following key assumptions:

 

Term (years)

 

 

3

 

Volatility

 

 

165.33 %

Risk-free rate

 

 

1.66

 

 

Stock-based compensation expense for the cost of the awards granted is based on the grant-date fair value. For stock option awards, the fair value is estimated at the date of grant using the Black-Scholes option-pricing model. This model requires the input of highly subjective assumptions, changes to which can materially affect the fair value estimate. Additionally, there may be other factors that would otherwise have a significant effect on the value of employee stock options granted but are not considered by the model. Accordingly, while management believes that the Black-Scholes option-pricing model provides a reasonable estimate of fair value, the model does not necessarily provide the best single measure of fair value for the Company’s employee stock options.

 

The following is a summary of stock option activity for the six months ended September 30, 2021:

 

 

 

Shares

 

 

Weighted Average Exercise Price

 

 

Weighted

Average Remaining Contractual Term

(In Years)

 

 

Aggregate

Intrinsic Value

 

Outstanding, March 31, 2021

 

 

60,000

 

 

$ 1.98

 

 

 

6.52

 

 

$ 3,083

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

(60,000 )

 

 

1.98

 

 

 

-

 

 

 

3,742

 

Forfeited/cancelled/expired

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding, at September 30, 2021

 

 

-

 

 

 

-

 

 

 

-

 

 

$ -

 

Exercisable, at September 30, 2021

 

 

-

 

 

$ -

 

 

 

-

 

 

$ -